Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why

By: David B. Sarwer, Temple University, The Conversation

Outlets: The Conversation

Published: November 21, 2025

Words: 1,193

Last Updated: 3 days, 18 hours ago

By David B. Sarwer, Temple University

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the monthly prices of these medications by hundreds of dollars.

For the past 25 years, I have treated people with obesity and have developed and studied treatments for the condition in both adults and adolescents. One major frustration of …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.